Form 15-15D Nissan Auto Receivables
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 333-229287-02
NISSAN AUTO RECEIVABLES 2019-C OWNER TRUST
(Exact name of registrant as specified in its charter)
One Nissan Way, Franklin, Tennessee 37067, (615) 725-1121
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
1.95978% Asset Backed Notes, Class A-1; 1.97% Asset Backed Notes, Class A-2a;
LIBOR + 0.24 % Asset Backed Notes, Class A-2b
1.93% Asset Backed Notes, Class A-3; 1.95% Asset Backed Notes, Class A-4
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☐ | |||
| Rule 12g-4(a)(2) |
☐ | |||
| Rule 12h-3(b)(1)(i) |
☐ | |||
| Rule 12h-3(b)(1)(ii) |
☐ | |||
| Rule 15d-6 |
☐ | |||
| Rule 15d-22(b) |
☒ |
Approximate number of holders of record as of the certification or notice date: 0
Pursuant to the requirements of the Securities Exchange Act of 1934 NISSAN AUTO RECEIVABLES 2019-C OWNER TRUST has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: March 25, 2024 |
NISSAN AUTO RECEIVABLES COMPANY II LLC, as Depositor | |||||
| By: | /s/ Douglas E. Gwin, Jr. | |||||
| Name: | Douglas E. Gwin, Jr. | |||||
| Title: | Assistant Treasurer | |||||
Matter No. 136605
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic
- Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
- Winseed Successfully Concludes Its Participation at IAA TRANSPORTATION 2026, Showcasing New Insights into Automotive AI and Global Brand Visibility
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share